|
Office for Human Research Protections (OHRP)Special Protections for Children as Research SubjectsWhen a proposed research study involves children and is supported or conducted by HHS, the research institution's Institutional Review Board (IRB) must take into consideration the special regulatory requirements that provide additional protection for the children who would be involved in the research. If the proposed research involves FDA-regulated products, then FDA's parallel regulations apply. FAQs on Research with Children By regulatory definition, children are persons who have not attained the legal age for consent to treatments or procedures involved in the research, under applicable law of the jurisdiction in which the research will be conducted. Generally the law considers any person under 18 years old to be a child. When reviewing research with children as subjects, in addition to ensuring adherence to the general regulatory requirements of 45 CFR part 46, Subpart A, the IRB also must consider the potential benefits, risks, and discomforts of the research to children and assess the justification for their inclusion in the research. In assessing the risks and potential benefits, the IRB should consider the circumstances of the children to be enrolled in the study-for example their health status, age, and ability to understand what is involved in the research-as well as potential benefits to subjects, other children with the same disease or condition, or society as a whole. For any protocol involving children, the IRB must determine which of the four categories of research apply to that study, if any. OHRP recommends that the IRB document the rationale for this choice. The HHS regulations at 45 CFR part 46, subpart D permit IRBs to approve three categories of research involving children as subjects:
45 CFR 46.404 - Research not involving greater than minimal risk to the children. To approve this category of research, the IRB must make the following determinations: 45 CFR 46.405 - Research involving greater than minimal risk but presenting the prospect of direct benefit to the individual child subjects involved in the research. To approve research in this category, the IRB must make the following determinations: 45 CFR 46.406 - Research involving greater than minimal risk and no prospect of direct benefit to the individual child subjects involved in the research, but likely to yield generalizable knowledge about the subject's disorder or condition. In order to approve research in this category, the IRB must make the following determinations: A fourth category of research requires a special level of HHS review beyond that provided by the IRB.
45 CFR 46.407 - Research that the IRB believes does not meet the conditions of 45 CFR 46.404, 46.405, or 46.406, but finds that the research presents a reasonable opportunity to further the understanding, prevention, or alleviation of a serious problem affecting the health or welfare of children. If the IRB believes that the research does not meet the requirements of 45 CFR 46.404, 46.405, or 46.406, but finds that it presents a reasonable opportunity to further the understanding, prevention, or alleviation of a serious problem affecting the health or welfare of children, it may refer the protocol to HHS for review. The research may proceed only if the Secretary, HHS, or his or her designee, after consulting with a panel of experts in pertinent disciplines (e.g., science, medicine, education, ethics, law) and following an opportunity for public review and comment, determines either: (1) that the research in fact satisfies the conditions of 45 CFR 46.404, 46.405, or 46.406, or (2) the following: For more information on the HHS 45 CFR 46.407 review process see OHRP Guidance, Children Involved as Subjects in Research: Guidance on the HHS 45 CFR 46.407 ("407") Review Process [PDF - 37.5KB] Related DocumentsProtections for Children in Research: A Report to Congress Research Protocols Being Reviewed Under 45 CFR 46.407Research Proposals Previously Reviewed under 45 CFR 46.407 |
Last revised: November 25, 2008